. Illustration of protrusive activity analysis. (a,b) Cell outlines at two consecutive time points (a) t 1 , and (b) t 2 . Blue indicates filopodia, orange indicates cell body. (c) Two cell bodies from (a) and (b) overlaid on top of each other. Yellow (cyan) areas indicate protruding (retracting) cell parts at t 2 with respect to t 1 . New area gain (yellow) at any given time point relative to average new area gain before rapamycin treatment (see Methods) was taken to assess the protrusive activity of the cell. Rate of area change was simply the derivative of the cell area. -18  -14  -10  -6  -2  2  6  10  14  18  22  26  30  34  38  42  46  50  54  58  62  66  70  74  78  82  86  90  Fold change in protrusive Supplementary Fig. 22 . Src autophosphorylation and paxillin phosphorylation when RapRSrc is activated in complex with either FAK or p130Cas. HEK293T cells co-expressing myctagged RapR-Src(R175L) with GFP-FRB or FAK-FRB-mVenus or p130Cas-FRB-mVenus were treated for with 0.5uM rapamycin for indicated period of time. Total cell lysates were analyzed by western blotting using antibodies for total protein or specific phospho-tyrosine residues. Levels of FAK-FRB and p130Cas-FRB were detected using anti-GFP antibody. Levels of RapR-Src were detected using anti-myc antibody. Fig. 25 . Phosphorylation status of endogenous FAK and p130Cas when RapR-Src is activated in complex with either FAK or p130Cas. HEK293T cells co-expressing RapR-Src(R175L) (SH2 domain mutant) and GFP-FRB or FAK-FRB-mVenus or p130Cas-FRB-mVenus construct were treated for with 0.5uM rapamycin for indicated period of time. Endogenous p130Cas and FAK were immunoprecipitated from the lysates and probed with anti-phospho-Tyr397 FAK and anti-phospho-Tyr410 p130Cas specific antibodies to evaluate Src-mediated phosphorylation of these proteins. 
